Upregulation of CDK2, the CDC25A phosphatase and DUSP14 in diabetes-free tumors is consistent with the tumor phenotype as these genes are reportedly overexpressed to stimulate cell proliferation and invasion in CRC [32,33,34]. The gene discussed is CDK2; the disease is colorectal carcinoma.